Epidural Test Dose - Most Common Dose    body {font-family: 'Open Sans', sans-serif; padding-left: 10px;}

### Epidural Test Dose - Most Common Dose

There is no "perfect" epidural test dose in the laboring mother to conclusively identify a  
a misplaced catheter.  
  
_There have been several case reports or case series published in which the test dose not only failed to identify the catheter misplacement but may even have induced a serious adverse event._  
  
The epinephrine in an epidural test dose is for ruling out an **intravascular** placed catheter.  
The lidocaine in an epidural test dose is for ruling out a **subarachnoid** placed catheter.  
  
First you need to know that there is conflicting literature concerning Epinephrine as an unreliable indicator of intravascular injection in a laboring mother.  
Epinephrine in test doses is associated with “false positives” and “false negatives” when assessing for unintentional intravascular insertion of an epidural needle. _Lidocaine and Epinephrine are the two most popular combinations in epidural test doses.  
  
_**Lidocaine and epinephrine are usually already mixed in your epidural cart in the same vial**  
1:200,000 Epinephrine and 1.5% Lidocaine are both usually already combined in a 5 mL test dose vial as part of the epidural kit. So drawing up 3 mLs in a syringe gives you 15mcg of epinephrine and 45mg of lidocaine. How simple is that?**The most popular and effective epidural test dose  
**3 mL of 1.5% lidocaine (45mg) with 15mcg of 1:200,000 epinephrine.  
  
**_Every bolus is a “test dose  
_**_There are many documented incidences of_ _late migrations of a previously functioning epidural catheter into an epidural vein resulting in local anesthetic systemic toxicity in a pregnant woman._ _This is why every bolus following the initial test dose should ONLY be 3-5 mLs._  
  
**Lidocaine  
**The most commonly used local anesthetic for a test dose is 1.5% PF Lidocaine (15mg/mL).  
Most common dose is 3 mLs (45 mg).  
A 1.5% PF Lidocaine comes in a 5 mL ampule in most epidural kits (already  
mixed with epinephrine).  
  
**Other Local anesthetics have been used but are not as popular  
**0.25% Bupivacaine with epinephrine – cardiotoxic  
2-chloroprocaine with epi – not as reliable as lidocaine for CNS symptoms  
**  
Epinephrine  
**1:200,000 Epinephrine commonly is added to the Lidocaine  
1:200,000 Epinephrine = 5mcg/mL (this is a weak concentration of epinephrine)  
3-5 mLs (15-45mcg) of epinephrine is the typical range  
A lidocaine 1.5% with 1:200,000 Epinephrine vial containing 5 mLs comes in most epidural kits.  
_Do not get the weak 1:200,000 Epinephrine (5mcg/mL) confused with the strong 1:1,000  
  
Epinephrine (1mg/mL) vials we see in the operating rooms, and which is included in most spinal trays._  
  
Local anesthetics should be injected only **3 to 5 mL** at a time, and the signs and symptoms of intravascular injection should be closely monitored.

    <!--table {mso-displayed-decimal-separator:"\\."; mso-displayed-thousand-separator:"\\,";} @page {margin:1.0in .75in 1.0in .75in; mso-header-margin:.5in; mso-footer-margin:.5in;} .font5 {color:black; font-size:8.0pt; font-weight:400; font-style:normal; text-decoration:none; font-family:Arial; mso-generic-font-family:auto; mso-font-charset:0;} .font6 {color:black; font-size:8.0pt; font-weight:400; font-style:normal; text-decoration:none; font-family:Symbol; mso-generic-font-family:auto; mso-font-charset:0;} .font7 {color:black; font-size:8.0pt; font-weight:400; font-style:normal; text-decoration:none; font-family:Calibri; mso-generic-font-family:auto; mso-font-charset:0;} .font8 {color:black; font-size:8.0pt; font-weight:400; font-style:normal; text-decoration:none; font-family:"Times New Roman"; mso-generic-font-family:auto; mso-font-charset:0;} .font9 {color:black; font-size:8.0pt; font-weight:700; font-style:normal; text-decoration:none; font-family:"Times New Roman"; mso-generic-font-family:auto; mso-font-charset:0;} .style0 {mso-number-format:General; text-align:general; vertical-align:bottom; white-space:nowrap; mso-rotate:0; mso-background-source:auto; mso-pattern:auto; color:black; font-size:12.0pt; font-weight:400; font-style:normal; text-decoration:none; font-family:Calibri, sans-serif; mso-font-charset:0; border:none; mso-protection:locked visible; mso-style-name:Normal; mso-style-id:0;} td {mso-style-parent:style0; padding-top:1px; padding-right:1px; padding-left:1px; mso-ignore:padding; color:black; font-size:12.0pt; font-weight:400; font-style:normal; text-decoration:none; font-family:Calibri, sans-serif; mso-font-charset:0; mso-number-format:General; text-align:general; vertical-align:bottom; border:none; mso-background-source:auto; mso-pattern:auto; mso-protection:locked visible; white-space:nowrap; mso-rotate:0;} .xl65 {mso-style-parent:style0; color:black; font-size:10.0pt; font-weight:700; font-family:Arial; mso-generic-font-family:auto; mso-font-charset:0; text-align:center; vertical-align:middle; border-top:1.0pt solid windowtext; border-right:1.0pt solid windowtext; border-bottom:1.0pt solid windowtext; border-left:none; white-space:normal;} .xl66 {mso-style-parent:style0; color:black; font-size:8.0pt; font-weight:700; font-family:Arial; mso-generic-font-family:auto; mso-font-charset:0; vertical-align:middle; border-top:none; border-right:1.0pt solid windowtext; border-bottom:none; border-left:1.0pt solid windowtext; white-space:normal;} .xl67 {mso-style-parent:style0; color:black; font-size:8.0pt; font-family:Arial; mso-generic-font-family:auto; mso-font-charset:0; vertical-align:middle; border-top:none; border-right:1.0pt solid windowtext; border-bottom:none; border-left:1.0pt solid windowtext; white-space:normal;} .xl68 {mso-style-parent:style0; color:black; font-size:10.0pt; font-weight:700; font-family:Arial; mso-generic-font-family:auto; mso-font-charset:0; text-align:center; vertical-align:middle; border-top:1.0pt solid windowtext; border-right:none; border-bottom:1.0pt solid windowtext; border-left:1.0pt solid windowtext; white-space:normal;} .xl69 {mso-style-parent:style0; color:black; font-size:10.0pt; font-weight:700; font-family:Arial; mso-generic-font-family:auto; mso-font-charset:0; text-align:center; vertical-align:middle; border-top:1.0pt solid windowtext; border-right:none; border-bottom:1.0pt solid windowtext; border-left:none; white-space:normal;} .xl70 {mso-style-parent:style0; color:black; font-size:8.0pt; font-weight:700; font-family:Arial; mso-generic-font-family:auto; mso-font-charset:0; vertical-align:middle; border-top:1.0pt solid windowtext; border-right:none; border-bottom:1.0pt solid windowtext; border-left:1.0pt solid windowtext; white-space:normal;} .xl71 {mso-style-parent:style0; color:black; font-size:8.0pt; font-weight:700; font-family:Arial; mso-generic-font-family:auto; mso-font-charset:0; vertical-align:middle; border-top:1.0pt solid windowtext; border-right:none; border-bottom:1.0pt solid windowtext; border-left:none; white-space:normal;} .xl72 {mso-style-parent:style0; color:black; font-size:8.0pt; font-weight:700; font-family:Arial; mso-generic-font-family:auto; mso-font-charset:0; vertical-align:middle; border-top:1.0pt solid windowtext; border-right:1.0pt solid windowtext; border-bottom:1.0pt solid windowtext; border-left:none; white-space:normal;} .xl73 {mso-style-parent:style0; color:black; font-size:8.0pt; font-family:Arial; mso-generic-font-family:auto; mso-font-charset:0; vertical-align:middle; border-top:1.0pt solid windowtext; border-right:none; border-bottom:1.0pt solid windowtext; border-left:1.0pt solid windowtext; white-space:normal;} .xl74 {mso-style-parent:style0; color:black; font-size:8.0pt; font-family:Arial; mso-generic-font-family:auto; mso-font-charset:0; vertical-align:middle; border-top:1.0pt solid windowtext; border-right:none; border-bottom:1.0pt solid windowtext; border-left:none; white-space:normal;} .xl75 {mso-style-parent:style0; color:black; font-size:8.0pt; font-family:Arial; mso-generic-font-family:auto; mso-font-charset:0; vertical-align:middle; border-top:1.0pt solid windowtext; border-right:1.0pt solid windowtext; border-bottom:1.0pt solid windowtext; border-left:none; white-space:normal;} .xl76 {mso-style-parent:style0; color:black; font-size:8.0pt; font-family:Arial; mso-generic-font-family:auto; mso-font-charset:0; vertical-align:middle; border-top:1.0pt solid windowtext; border-right:1.0pt solid windowtext; border-bottom:none; border-left:1.0pt solid windowtext; white-space:normal;} .xl77 {mso-style-parent:style0; color:black; font-size:8.0pt; font-weight:700; font-family:Arial; mso-generic-font-family:auto; mso-font-charset:0; vertical-align:middle; border-top:1.0pt solid windowtext; border-right:1.0pt solid windowtext; border-bottom:none; border-left:1.0pt solid windowtext; white-space:normal;} .xl78 {mso-style-parent:style0; color:black; font-size:8.0pt; font-weight:700; font-family:Arial; mso-generic-font-family:auto; mso-font-charset:0; vertical-align:middle; border:1.0pt solid windowtext; white-space:normal;} .xl79 {mso-style-parent:style0; font-size:8.0pt; vertical-align:middle; border-top:1.0pt solid windowtext; border-right:1.0pt solid windowtext; border-bottom:1.0pt solid windowtext; border-left:none; white-space:normal;} .xl80 {mso-style-parent:style0; color:#0081AD; font-size:8.0pt; font-family:Arial; mso-generic-font-family:auto; mso-font-charset:0; vertical-align:middle; border:1.0pt solid windowtext; white-space:normal;} .xl81 {mso-style-parent:style0; font-size:8.0pt; font-family:"Times New Roman"; mso-generic-font-family:auto; mso-font-charset:0; text-align:left; vertical-align:121; border-top:1.0pt solid windowtext; border-right:1.0pt solid windowtext; border-bottom:none; border-left:1.0pt solid windowtext; white-space:normal;} .xl82 {mso-style-parent:style0; font-size:8.0pt; font-family:"Times New Roman"; mso-generic-font-family:auto; mso-font-charset:0; text-align:left; vertical-align:121; border-top:none; border-right:1.0pt solid windowtext; border-bottom:none; border-left:1.0pt solid windowtext; white-space:normal;} .xl83 {mso-style-parent:style0; font-size:8.0pt; font-family:"Times New Roman"; mso-generic-font-family:auto; mso-font-charset:0; text-align:left; vertical-align:121; border-top:none; border-right:1.0pt solid windowtext; border-bottom:1.0pt solid windowtext; border-left:1.0pt solid windowtext; white-space:normal;} -->

<table border="0" cellpadding="0" cellspacing="0" width="862" style="border-collapse:
					 collapse;table-layout:fixed;width:862pt"><colgroup><col width="109" style="mso-width-source:userset;mso-width-alt:4650;width:109pt"> <col width="131" style="mso-width-source:userset;mso-width-alt:5589;width:131pt"> <col width="110" style="mso-width-source:userset;mso-width-alt:4693;width:110pt"> <col width="512" style="mso-width-source:userset;mso-width-alt:21845;width:512pt"></colgroup><tbody><tr height="16" style="height:16.0pt;mso-yfti-firstrow:yes;mso-yfti-irow:0"><td colspan="3" height="16" class="xl68" width="350" style="border-right:1.0pt solid black;
					  height:16.0pt;width:350pt">Epidural Test Dose Regimens</td><td class="xl65" width="512" style="width:512pt">Minimizing LA toxicity</td></tr><tr height="44" style="mso-height-source:userset;height:44.0pt;mso-yfti-irow:
					  1"><td height="44" class="xl77" width="109" style="height:44.0pt;border-top:none;
					  width:109pt">Test Dose Components</td><td class="xl77" width="131" style="border-top:none;border-left:none;width:131pt">Positive Intravascular T. D.</td><td class="xl77" width="110" style="border-top:none;border-left:none;width:110pt">Positive Intrathecal T. D.</td><td rowspan="5" class="xl81" width="512" style="border-bottom:1.0pt solid black;
					  border-top:none;width:512pt">* <font class="font9">Lower the proximal end</font><font class="font8"> of the catheter below the site of insertion, </font><font class="font9">observe for the passive return of blood or CSF</font><font class="font8">.<br><br>* Aspirate before injecting each dose of LA.<br><br>* Give the test dose between uterine contractions.<br><br>* Use dilute solutions of LA during labor.<br><br>* Do not inject more than 5 mL of LA as a single bolus.<span style="mso-spacerun:yes">&nbsp;</span><br><br>* Maintain verbal contact with the patient.<span style="mso-spacerun:yes">&nbsp;</span><br><br>* If little or no block is produced after the injection of an appropriate dose of LA, assume that the local anesthetic was injected IV and remove the catheter.<br><br><br><br><br><br></font></td></tr><tr height="16" style="height:16.0pt;mso-yfti-irow:2"><td colspan="3" height="16" class="xl70" width="350" style="border-right:1.0pt solid black;
					  height:16.0pt;width:350pt">Combined Intrathecal and Intravenous T.D<font class="font5">.</font></td></tr><tr height="41" style="height:41.0pt;mso-yfti-irow:3"><td height="41" class="xl67" width="109" style="height:41.0pt;width:109pt">Lidocaine 1.5% with epinephrine 5 <font class="font6">m</font><font class="font5">g/mL: 3 mL<span style="mso-spacerun:yes">&nbsp;</span><br>Bupivacaine 0.25% with epinephrine 5 mg/mL: 3 mL</font></td><td class="xl76" width="131" style="border-top:none;border-left:none;width:131pt">Increase in HR of 20 bpm within 1 min</td><td class="xl76" width="110" style="border-top:none;border-left:none;width:110pt">Motor blockade at 3 – 5 min</td></tr><tr height="72" style="mso-height-source:userset;height:72.0pt;mso-yfti-irow:
					  4"><td height="72" class="xl78" width="109" style="height:72.0pt;width:109pt"><span>Intravenous Test Dose:<br><font class="font5">Lidocaine 100 mg<span style="mso-spacerun:yes">&nbsp;</span><br>Bupivacaine 25 mg<span style="mso-spacerun:yes">&nbsp;</span><br>2-Chloroprocaine 100 mg<span style="mso-spacerun:yes">&nbsp;</span><br>Fentanyl 100 mg<span style="mso-spacerun:yes">&nbsp;&nbsp;</span><br>Air 1 mL</font></span></td><td class="xl79" width="131" style="width:131pt">Tinnitus, circumoral numbness, dizziness<span style="mso-spacerun:yes">&nbsp;</span><br>Dizziness, drowsiness<span style="mso-spacerun:yes">&nbsp;</span><br>Change in Doppler heart sounds over right side of heart</td><td class="xl80" width="110" style="border-left:none;width:110pt">&nbsp;</td></tr><tr height="31" style="height:31.0pt;mso-yfti-irow:5"><td height="31" class="xl66" width="109" style="height:31.0pt;width:109pt">Intrathecal Test Dose:<br><font class="font5">Lidocaine 40-60 mg<span style="mso-spacerun:yes">&nbsp;</span><br>Bupivacaine 7.5 mg<span style="mso-spacerun:yes">&nbsp;</span></font></td><td class="xl67" width="131" style="border-left:none;width:131pt">&nbsp;</td><td class="xl67" width="110" style="border-left:none;width:110pt">Motor blockade at 3 – 5 min</td></tr><tr height="21" style="mso-height-source:userset;height:21.0pt;mso-yfti-irow:
					  6;mso-yfti-lastrow:yes"><td colspan="4" height="21" class="xl73" width="862" style="border-right:1.0pt solid black;
					  height:21.0pt;width:862pt">T.D. may be less sensitive in premedicated patients, patients treated with a <font class="font7">β-</font><font class="font5">adrenergic antagonist.</font></td></tr></tbody></table>

Chestnut, David.(2014) Chestnut’s Obstetric Anesthesia Principles and Practice.  
  
Santos, Alan., Epstein, Jonathan.,(2015) Chaudhuri, Kallol Obstetric Anesthesia ; 2015.  
  
IFNA / International Federation of Nurse AnesthetistsDeveloping Countries Regional Anesthesia Lecture SeriesDaniel D. Moos CRNA, Ed.D. U.S.A.